Efficacy of the combined therapy with Rituximab plus Cyclophosphamide versus Cyclophosphamide as Monotherapy in Systemic Sclerosis-Associated Interstitial Lung Disease

被引：0
|
作者：
Tejeda-Andrade, C. F. [1 ]
Villalpando-Gomez, Y. [1 ]
Gamez-Nava, J., I [1 ]
Castro-Lizano, N. [1 ]
Rocha-Munoz, A. D. [1 ]
Cardona, Munoz E. G. [1 ]
Gonzalez-Lopez, L. [1 ]
机构：
[1] Univ Guadalajara, CUCS, Unidad Invest Cardiovasc, Guadalajara, Jalisco, Mexico
来源：
JOURNAL OF RHEUMATOLOGY | 2011年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1193 / 1193
页数：1
相关论文
共 50 条
  • [31] Lung transplantation for systemic sclerosis-associated interstitial lung disease
    Le Pavec, J.
    Launay, D.
    Cottin, V.
    Reynaud-Gaubert, M.
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 : E73 - E79
  • [32] Nintedanib for systemic sclerosis-associated interstitial lung disease
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (11): : E755 - E755
  • [33] Nintedanib for systemic sclerosis-associated interstitial lung disease
    Rahimi, Susan
    LANCET RESPIRATORY MEDICINE, 2020, 8 (02): : 136 - 136
  • [34] Efficacy of Rituximab in Systemic Sclerosis with Interstitial Lung Disease
    Onat, Ahmet Mesut
    Zengin, Orhan
    Aksoy, Savas
    Onder, Mustafa Erkut
    Sacinti, Koray Gorkem
    Kisacik, Bunyamin
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [35] THE EFFECT OF CYCLOPHOSPHAMIDE ON LUNG FUNCTION IN DIFFERENT STAGES OF INTERSTITIAL LUNG DISEASE ASSOCIATED TO SYSTEMIC SCLEROSIS
    Van Den Hombergh, W. M. T.
    Teesselink, E.
    Knaapen-Hans, H. K. A.
    Simons, S. O.
    van den Hoogen, F. H. J.
    Fransen, J.
    Vonk, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 526 - 526
  • [36] A new therapy for systemic sclerosis-associated interstitial disease
    Kondoh, Yasuhiro
    RESPIRATORY INVESTIGATION, 2020, 58 (04) : 227 - 229
  • [37] PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Cuomo, G.
    Di Vico, C.
    Perretta, D.
    Iandoli, C.
    Ciaburri, R.
    Adamo, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1657 - 1658
  • [38] Rituximab treatment for systemic sclerosis-associated interstitial lung disease: a case series of 13 patients
    Morgan, Kelly
    Woollard, Charlotte
    Beinart, Dylan
    Host, Lauren, V
    Roddy, Janet
    INTERNAL MEDICINE JOURNAL, 2023, 53 (07) : 1147 - 1153
  • [39] Predictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial
    Kuzumi, Ai
    Oba, Koji
    Ebata, Satoshi
    Kashiwabara, Kosuke
    Ueda, Keiko
    Uemura, Yukari
    Watadani, Takeyuki
    Fukasawa, Takemichi
    Miura, Shunsuke
    Yoshizaki-Ogawa, Asako
    Kage, Hidenori
    Sato, Shinichi
    Yoshizaki, Ayumi
    RHEUMATOLOGY, 2025,
  • [40] Safety and Tolerability of Cyclophosphamide Versus Mycophenolate for Systemic Sclerosis-Related Interstitial Lung Disease
    Volkmann, Elizabeth R.
    Roth, Michael
    Elashoff, Robert
    Clements, Philip J.
    Furst, Daniel E.
    Khanna, Dinesh
    Goldin, Jonathan
    Tashkin, Donald
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345